Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

N. Thatcher, Alex Y. Chang, Purvish Mahendra Parikh et al. · The Lancet · 2005

Cited by 2,081 works. doi:10.1016/s0140-6736(05)67625-8

Authors

References